You just read:

Astellas Announces First Clinical Data from Phase I Study of Gilteritinib in Combination with Intensive Chemotherapy in Patients Newly Diagnosed with Acute Myeloid Leukemia

News provided by

Astellas Pharma Inc.

Dec 11, 2017, 13:45 EST